Nasal Spray Kit
A spray bottle and diluent supplied for preparing a peptide as a nasal solution; a consumable, not a research compound.
- Purity
- 99.2%
- Lot
- PU-7F28
- Format
- Consumable kit
- Third-party tested
- Discreet packaging
- Same-day shipping
- Encrypted checkout
For research use only. Not for human consumption.
Mechanism of Action
This is a consumable kit with no pharmacological mechanism of its own. Its function is to hold a reconstituted peptide solution in a metered-spray container for intranasal delivery in a research setting.
The relevant published literature concerns the nasal route itself. Nose-to-brain delivery has been reviewed in Pharmaceutics and Bioorganic and Medicinal Chemistry, with attention to why the nasal epithelium is studied as a route that partly bypasses the blood-brain barrier and why bioavailability by that route is variable and formulation-dependent.
Research Findings
Indexed work covers nose-to-brain delivery of therapeutic peptides as nasal aerosols, nanoparticle and liposomal carriers, and microneedle-mediated approaches. Reported endpoints are pharmacokinetic and biodistribution measures in animal models.
These references describe the route, not this kit. Recovery and stability of any given peptide in a spray device must be established for that peptide rather than assumed from the class literature.
Storage & Reconstitution
Components are stored sealed at controlled room temperature until assembly, protected from light. The bottle, actuator and supplied diluent are single-use for a given preparation; the assembled device is not disassembled, cleaned and refilled with a second preparation.
When preparing the solution, the diluent is added to the peptide vial rather than the reverse, down the vial wall and with swirling rather than shaking. The resulting solution is transferred once, into the spray bottle, and the number of transfer steps is kept to a minimum - each one costs material to adsorption and adds a contamination opportunity.
The assembled device is stored upright at 2-8 degrees C and protected from light. The kit should be labelled with the peptide identity, the lot number and the date of assembly so that any observation can be traced to a certificate of analysis.
- Contents
- Spray bottle, actuator, diluent
- Sealed storage
- Controlled room temperature
- After assembly
- Upright, 2-8 C, protected from light
- Use
- Single preparation per device
- Avoid
- Disassembly, refilling, shaking
Handling summary
References
No indexed literature exists for this item specifically. The entries below are class-level references on peptide formulation, delivery and handling, listed as background rather than as evidence about this product.
- [1]Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment(opens PubMed in a new tab)
J Control Release · 2024 · PMID 38219911
- [2]Nose-to-brain peptide delivery - The potential of nanotechnology(opens PubMed in a new tab)
Bioorg Med Chem · 2018 · PMID 29170026
- [3]Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles(opens PubMed in a new tab)
Drug Deliv Transl Res · 2019 · PMID 30887226
- [4]Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols(opens PubMed in a new tab)
Pharmaceutics · 2022 · PMID 36145618
- [5]
- [6]Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges(opens PubMed in a new tab)
Drug Discov Today · 2019 · PMID 31181188